Almujtama Alraida Medical Co.

9592.SRSAUHealthcare● Active

$24.60

+$1.10(+4.68%)

Market Cap$233700000

P/E Ratio—

52W High$33.5

52W Low$22

Avg Volume3K

Open$24.60

Beta0.15

Cash on Hand Financials Revenue

Almujtama Alraida Medical Co. (9592.SR) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

9592.SR · cash on hand · updated Dec 31, 2024

Core cash position

as of Dec 31, 2024

Cash & Short-Term Investments (CCE + ST Investments)

$2.2M▼ -83.2% vs prior year

FY · as of Dec 31, 2024 · Reported in SAR

Cash & Cash Equiv. (CCE)

$2.2M

cashAndCashEquivalents

Short-Term Investments

shortTermInvestments

YoY Change vs Prior Year

-83.2%

vs prior fiscal year

Latest Quarter

$6.8M

Q2 2025

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in SAR

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2024

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$2.2MCash on Hand

Total Debt$170.4MTotal Debt

Net Cash / Net Debt−$168.2MNet Debt Position

Cash vs Debt Ratio

Cash 1%Almujtama Alraida Medical Co. cash as % of market cap: 0.93%% · MCap $0BDebt 99%

Almujtama Alraida Medical Co. carries a net debt position of $168.2M. Total debt ($170.4M) exceeds cash on hand ($2.2M). Almujtama Alraida Medical Co. cash vs debt ratio: 1% cash / 99% debt.

Net Cash = Cash & ST Investments − Total Debt$2.2M − $170.4M = −$168.2M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

9592.SR annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

9592.SR cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2024LatestFY$2.2M-83.2%

Dec 31, 2023FY$13.0M+220.6%

Dec 31, 2022FY$4.1M-3.9%

Dec 31, 2021FY$4.2M—

9592.SR cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

9592.SR vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Almujtama Alraida Medical Co.YOU

9592.SR

$2.2M$234M0.9%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Almujtama Alraida Medical Co. (9592.SR) cash on hand as of December 31, 2024 is $2.2M, comprising $2.2M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Almujtama Alraida Medical Co. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Almujtama Alraida Medical Co. cash reserves or cash position.

Almujtama Alraida Medical Co. annual cash on hand history shows decreased -83.2% in 2024: decreased -83.2% in 2024. Almujtama Alraida Medical Co. cash reserves in 2024 reflect the company's capital allocation strategy.

Almujtama Alraida Medical Co. carries total debt of $170.4M against cash of $2.2M, resulting in a net debt position of -$168.2M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

9592.SR cash on hand · 5 questions

As of December 31, 2024, Almujtama Alraida Medical Co. (9592.SR) has $2,179,548 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $2,179,548 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (June 30, 2025): $6,784,325. Data sourced from the annual 10-K filing via FMP.

9592.SR cash on hand9592.SR cash reserves9592.SR cash 2024how much cash does 9592.SR have

▸ Source: FMP /balance-sheet-statement · US GAAP · Almujtama Alraida Medical Co. · Almujtama Alraida Medical Co. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2024